ATE359291T1 - Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna - Google Patents
Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dnaInfo
- Publication number
- ATE359291T1 ATE359291T1 AT99908097T AT99908097T ATE359291T1 AT E359291 T1 ATE359291 T1 AT E359291T1 AT 99908097 T AT99908097 T AT 99908097T AT 99908097 T AT99908097 T AT 99908097T AT E359291 T1 ATE359291 T1 AT E359291T1
- Authority
- AT
- Austria
- Prior art keywords
- breast cancer
- bcrp
- dna coding
- resistance protein
- cancer resistance
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/44—Multiple drug resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7376398P | 1998-02-05 | 1998-02-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE359291T1 true ATE359291T1 (de) | 2007-05-15 |
Family
ID=22115664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99908097T ATE359291T1 (de) | 1998-02-05 | 1999-02-05 | Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna |
Country Status (10)
Country | Link |
---|---|
US (4) | US6313277B1 (de) |
EP (1) | EP1054894B2 (de) |
JP (1) | JP4187412B2 (de) |
AT (1) | ATE359291T1 (de) |
AU (1) | AU755567B2 (de) |
CA (1) | CA2319715C (de) |
DE (1) | DE69935782T3 (de) |
ES (1) | ES2284243T5 (de) |
IL (4) | IL137466A0 (de) |
WO (1) | WO1999040110A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2284243T5 (es) * | 1998-02-05 | 2017-08-22 | University Of Maryland Baltimore | Proteína de resistencia de cáncer de mama (BCRP) y el ADN que la codifica |
US7622557B2 (en) * | 1998-05-28 | 2009-11-24 | St. Jude Children's Research Hospital | Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP) |
WO1999061589A2 (en) | 1998-05-28 | 1999-12-02 | St. Jude Children's Research Hospital | Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof |
US7138493B1 (en) * | 1998-11-30 | 2006-11-21 | The United States Of America As Represented By The Department Of Health And Human Services | ATP-binding cassette protein responsible for cytotoxin resistance |
AU1924000A (en) * | 1998-11-30 | 2000-07-03 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | An atp-binding cassette protein responsible for cytotoxin resistance |
WO2000069390A2 (en) * | 1999-05-17 | 2000-11-23 | Cancer Research Ventures Limited | Compositions for improving bioavailability of orally administered drugs |
AU2001288061A1 (en) * | 2000-10-03 | 2002-04-15 | Banyu Pharmaceutical Co., Ltd. | Drug resistance-associated gene and use thereof |
HU0100947D0 (en) * | 2001-03-02 | 2001-05-28 | Solvo Kft | Screening system based on expression of abcg2 half transporter protein in an expression system free of other abc-transporters, abcg2 homodimers |
WO2003035685A1 (en) * | 2001-10-24 | 2003-05-01 | Solvo Biotechnology Inc. | Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy |
US20060135445A1 (en) * | 2003-02-04 | 2006-06-22 | Kabushiki Kaisha Yakult Honsha | Breast cancer-resistant protein inhibitor |
JP2006069910A (ja) * | 2004-08-31 | 2006-03-16 | Yoshiichi Sugimoto | 抗癌剤耐性克服剤 |
EP1672365A1 (de) * | 2004-12-16 | 2006-06-21 | Het Nederlands Kanker Instituut | Mittel und Verfahren zur Bestimmung und Beeinflussung des zellulären Transports |
US7465788B2 (en) * | 2005-01-18 | 2008-12-16 | University Of Maryland | Breast cancer resistance protein (BCRP) and antibodies thereto |
CN108949694B (zh) | 2012-09-11 | 2022-06-17 | 康宁有限公司 | 瞬时过表达编码药物转运蛋白和/或药物代谢酶的基因的可消耗的低温保存的细胞 |
KR101561965B1 (ko) | 2013-11-27 | 2015-10-20 | 한국과학기술연구원 | 디스코이딘 도메인 수용체 2 활성을 조절하는 물질의 동정 방법 |
EP3966340A4 (de) * | 2019-05-08 | 2024-01-03 | The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo | Terpen-synthasen und transporter |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5585479A (en) * | 1992-07-24 | 1996-12-17 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ELAM-I RNA |
US5489519A (en) * | 1992-10-27 | 1996-02-06 | Queen's University At Kingston | Multidrug resistance protein |
EP0975795A1 (de) * | 1997-02-24 | 2000-02-02 | TM Technologies Inc. | Verfahren zur selektion von anti-strang-oligonukleotiden |
WO1998055614A2 (en) * | 1997-06-04 | 1998-12-10 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
ES2284243T5 (es) * | 1998-02-05 | 2017-08-22 | University Of Maryland Baltimore | Proteína de resistencia de cáncer de mama (BCRP) y el ADN que la codifica |
JP2002534055A (ja) * | 1998-05-14 | 2002-10-15 | カイロン コーポレイション | ヒト遺伝子および遺伝子発現産物v |
CA2344107A1 (en) * | 1998-09-25 | 2000-04-06 | Bayer Aktiengesellschaft | Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
AU1924000A (en) * | 1998-11-30 | 2000-07-03 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | An atp-binding cassette protein responsible for cytotoxin resistance |
AU2001288061A1 (en) | 2000-10-03 | 2002-04-15 | Banyu Pharmaceutical Co., Ltd. | Drug resistance-associated gene and use thereof |
JP2005529618A (ja) | 2002-06-17 | 2005-10-06 | 萬有製薬株式会社 | Abcg2多型による薬物輸送能の予測方法 |
-
1999
- 1999-02-05 ES ES99908097.1T patent/ES2284243T5/es not_active Expired - Lifetime
- 1999-02-05 WO PCT/US1999/002577 patent/WO1999040110A1/en active IP Right Grant
- 1999-02-05 IL IL13746699A patent/IL137466A0/xx unknown
- 1999-02-05 US US09/245,808 patent/US6313277B1/en not_active Expired - Lifetime
- 1999-02-05 AU AU27610/99A patent/AU755567B2/en not_active Expired
- 1999-02-05 AT AT99908097T patent/ATE359291T1/de not_active IP Right Cessation
- 1999-02-05 CA CA2319715A patent/CA2319715C/en not_active Expired - Lifetime
- 1999-02-05 DE DE69935782.9T patent/DE69935782T3/de not_active Expired - Lifetime
- 1999-02-05 JP JP2000530538A patent/JP4187412B2/ja not_active Expired - Lifetime
- 1999-02-05 EP EP99908097.1A patent/EP1054894B2/de not_active Expired - Lifetime
-
2000
- 2000-07-24 IL IL137466A patent/IL137466A/en not_active IP Right Cessation
-
2001
- 2001-09-21 US US09/961,086 patent/US7541437B2/en not_active Expired - Fee Related
-
2005
- 2005-07-20 US US11/184,860 patent/US7655755B2/en not_active Expired - Fee Related
-
2006
- 2006-08-21 IL IL177612A patent/IL177612A/en not_active IP Right Cessation
-
2008
- 2008-04-01 US US12/060,738 patent/US7741445B2/en not_active Expired - Fee Related
- 2008-06-05 IL IL191982A patent/IL191982A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US7541437B2 (en) | 2009-06-02 |
WO1999040110A1 (en) | 1999-08-12 |
US7655755B2 (en) | 2010-02-02 |
JP4187412B2 (ja) | 2008-11-26 |
EP1054894A1 (de) | 2000-11-29 |
AU755567B2 (en) | 2002-12-12 |
EP1054894B2 (de) | 2016-11-09 |
JP2002502592A (ja) | 2002-01-29 |
EP1054894B1 (de) | 2007-04-11 |
IL137466A0 (en) | 2001-07-24 |
IL137466A (en) | 2011-04-28 |
US20030036645A1 (en) | 2003-02-20 |
ES2284243T5 (es) | 2017-08-22 |
DE69935782T3 (de) | 2017-01-05 |
IL191982A (en) | 2011-09-27 |
IL191982A0 (en) | 2008-12-29 |
AU2761099A (en) | 1999-08-23 |
CA2319715A1 (en) | 1999-08-12 |
EP1054894A4 (de) | 2002-03-13 |
DE69935782T2 (de) | 2007-08-16 |
DE69935782D1 (de) | 2007-05-24 |
US20050272684A1 (en) | 2005-12-08 |
US7741445B2 (en) | 2010-06-22 |
US6313277B1 (en) | 2001-11-06 |
CA2319715C (en) | 2012-08-07 |
IL177612A (en) | 2011-04-28 |
ES2284243T3 (es) | 2007-11-01 |
US20090104199A1 (en) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL191982A0 (en) | Breast cancer resistance protein (bcrp) and the dna which encodes it | |
EA199700447A1 (ru) | Последовательность днк и кодируемый ею специфический для молочной железы белок карциномы молочной железы | |
CY1112101T1 (el) | Νευροτροφικοι παραγοντες | |
ATE415480T1 (de) | B7l-1 moleküle | |
DE69841110D1 (de) | Verlängerte cdns, die für sekretierte proteine kodieren | |
DE60227974D1 (de) | Diagnostische tests auf periostinbasis | |
IL193886A (en) | Antibodies that bind to ldcam sequences | |
DE69936351D1 (de) | Glykosylierte proteine mit reduzierter allergenität | |
SG157952A1 (en) | Small molecule antagonists of bcl-2 family proteins | |
ES2077666T3 (es) | Proteina de union a fibronectina y su preparacion. | |
DK1104425T3 (da) | Hidtil ukendte thiazolopyrimidinforbindelser | |
SI1392830T1 (sl) | Mutanti interlevkina-18, njihova proizvodnja in uporaba | |
ATE473279T1 (de) | In metastatischen menschlichen tumorzellen exprimiertes glycoproteinantigen sima135 | |
AU3392901A (en) | Proteins | |
ES2192199T3 (es) | Ligandos de la familia eph biologicamente activos. | |
SG165168A1 (en) | New adenoviruses, nucleic acids coding therefor and their use | |
ATE368733T1 (de) | Bfit (brown fat inducible thioesterase) polypeptide und polynukleotide und ihre verwendung | |
CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του | |
PT1045914E (pt) | Proteinase svph1-8 humana especifica de testiculo | |
ATE408687T1 (de) | Semaphorin polypeptide | |
DK0858465T3 (da) | Protein med antitumorvirkning. | |
SE0003099D0 (sv) | Adhesive protein and uses therefore | |
ATE438660T1 (de) | Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide | |
DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide | |
AU2002317527A1 (en) | Breast Cancer Resistance Protein (BCRP) and the DNA Which Encodes It |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |